84 related articles for article (PubMed ID: 189271)
1. [Antibodies against the Epstein-Barr Virus nuclear-antigen in children with malignant disease (author's transl)].
Lubec G; Jürgenssen O
Osterr Z Onkol; 1976; 3(4):96-9. PubMed ID: 189271
[TBL] [Abstract][Full Text] [Related]
2. [Antibodies against the Epstein-Barr virus, capsid antigen in children with malignant neoplasms (author's transl)].
Lubec G; Krepler P
Padiatr Padol; 1976; 11(1):88-93. PubMed ID: 175342
[TBL] [Abstract][Full Text] [Related]
3. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
Kuljić-Kapulica N
Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
[TBL] [Abstract][Full Text] [Related]
4. Humoral antibodies to the capsid antigen of Epstein-Barr virus in Hodgkin's disease.
Stepina VN; Gourtsevicz VE; Mazurenko NP; Yarymova NM; Kaverznyeva MM; Lorye YI
Neoplasma; 1976; 23(5):523-32. PubMed ID: 185535
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus (EBV) antibodies in children with non-Hodgkin's lymphomas.
Roubalová K; Weinreb M; Roubal J; Kodet R; Koutecký J; Vonka V
Acta Virol; 1988 Jul; 32(4):339-48. PubMed ID: 2903639
[TBL] [Abstract][Full Text] [Related]
6. [Levels of Epstein-Barr virus antibodies in the serum of children with acute lymphoblastic leukemia].
Holý J; Hrodek O; Hynieová H; Petrtýlová K; Srajer J; Vanĕcek K
Cesk Pediatr; 1981 May; 36(5):248-53. PubMed ID: 6266677
[No Abstract] [Full Text] [Related]
7. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.
Berkel AI; Henle W; Henle G; Ersoy F; Sanal O; Klein G; Yeğin O
Kroc Found Ser; 1985; 19():287-300. PubMed ID: 2999343
[TBL] [Abstract][Full Text] [Related]
8. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
[TBL] [Abstract][Full Text] [Related]
9. [Epstein-Barr virus and infectious mononucleosis. A clinical study of Epstein-Barr antibodies (author's transl)].
Seigneurin JM; Kressmann MC; Lavoué MF; Saez G; Lenoir G
Nouv Presse Med; 1978 Dec; 7(44):4005-10. PubMed ID: 215969
[TBL] [Abstract][Full Text] [Related]
10. Invited discussion: relationship of titers of Epstein-Barr virus to cell-mediated immunity in patients with Hodgkin's disease.
Levine PH; Reisher JI
Natl Cancer Inst Monogr; 1973 May; 36():85-7. PubMed ID: 4355354
[No Abstract] [Full Text] [Related]
11. Antibody against synthetic peptide derived from Epstein-Barr virus-determined nuclear antigen 1 (EBNA-1) in child non-Hodgkin's lymphoma.
Sova P; Roubalová K; Weinreb M; Hamsíková E; Kodet R; Krchnák V; Roubal J
Acta Virol; 1990 Apr; 34(2):132-8. PubMed ID: 1975974
[TBL] [Abstract][Full Text] [Related]
12. Correlation between mixed lymphocyte cultures and anti-Epstein Barr virus (EBV) antibodies in Hodgkin's disease and non Hodgkin lymphoma patients.
Sasiain MC; Fejes M; Ares BR; Brezavscek D; Bachmann AE
Biomedicine; 1981 Oct; 35(5):153-6. PubMed ID: 6274439
[TBL] [Abstract][Full Text] [Related]
13. Cells containing Epstein--Barr nuclear antigen (EBNA) in peripheral blood.
Gergely L; Czeglédy J; Váczi L; Szalka A; Berényi E
Acta Microbiol Acad Sci Hung; 1979; 26(1):41-5. PubMed ID: 225932
[TBL] [Abstract][Full Text] [Related]
14. Cell-mediated immune reactions in three patients with malignant lymphoproliferative diseases in remission and abnormally high Epstein-Barr virus antibody titers.
Masucci MG; Szigeti R; Ernberg I; Björkholm M; Mellstedt H; Henle G; Henle W; Pearson G; Masucci G; Svedmyr E; Johansson B; Klein G
Cancer Res; 1981 Nov; 41(11 Pt 1):4292-301. PubMed ID: 6272973
[TBL] [Abstract][Full Text] [Related]
15. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-related serology in Hodgkin's disease.
Henle W; Henle G
Natl Cancer Inst Monogr; 1973 May; 36():79-84. PubMed ID: 4355353
[No Abstract] [Full Text] [Related]
17. The Epstein-Barr virus (EBV) in human pathology. Results of a serological investigation of a hospital population.
Dalens M; Didier J; Pris J; Enjalbert L
Biomedicine; 1973 Jul; 18(4):336-45. PubMed ID: 4139980
[No Abstract] [Full Text] [Related]
18. Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies.
Lindahl T; Klein G; Reedman BM; Johansson B; Singh S
Int J Cancer; 1974 Jun; 13(6):764-72. PubMed ID: 4137165
[No Abstract] [Full Text] [Related]
19. [Malignant lymphoma which contained EBV DNA and lacked EBNA2 antibody].
Shimakage M; Hirai K; Ikegami N; Matsubuchi T; Kawagoe H
Rinsho Ketsueki; 1989 Jul; 30(7):1091-2. PubMed ID: 2554014
[TBL] [Abstract][Full Text] [Related]
20. Presence of complement-fixing antibodies against antigens of Gross virus-induced rat lymphoma and normal rat thymus in sera of patients with some forms of malignancies.
Simkovic D; Chorváth B; Hlubinová K; Valentová N; Stevonková J; Babusíková O; Simkovicová M
Neoplasma; 1977; 24(4):357-63. PubMed ID: 269322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
